Compounds as tyrosine kinase modulators

Details for Australian Patent Application No. 2010289359 (hide)

Owner Allergan, Inc.

Inventors Guo, Xialing; Zhu, Zhen

Agent Davies Collison Cave

Pub. Number AU-A-2010289359

PCT Pub. Number WO2011/029001

Priority 61/360,531 01.07.10 US; 61/239,603 03.09.09 US; 61/306,616 22.02.10 US; 61/356,699 21.06.10 US

Filing date 3 September 2010

Wipo publication date 10 March 2011

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/4365 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

29 March 2012 PCT application entered the National Phase

  PCT publication WO2011/029001 Priority application(s): WO2011/029001

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010289372-Method for generating a gas which may be used for startup and shutdown of a fuel cell

2010289358-Stable alkoxylated fatty acid alkyl esters from transesterification-alkoxylation of vegetable oils